Gene Signature-Based Drug Repositioning
With the advent of dynamical omics technology, especially the transcriptome and proteome, a huge amount of data related to various diseases and approved drugs are available under multi global projects or researches with their interests. These omics data and new machine learning technology largely pr...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/79414 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Gene Signature-Based Drug Repositioning
- Drug Repositioning in the AI-Driven Era: Data, Approaches, and Challenges
- The Potential Benefits of Drug-Repositioning in Muscular Dystrophies
- Computational Drug Repositioning Method Applied to Lung Cancer
- Drug Repositioning for the Treatment of Glioma: Current State and Future Perspective
- Translational Research on Chagas Disease: Focusing on Drug Combination and Repositioning
- Drug repositioning : bringing new life to shelved assets and existing drugs /